Medical Letter on the CDC & FDA articles from November 2004

Medical Letter on the CDC & FDA archives from November 2004

N-ethyl-N-nitrosourea increases brain mutations in neonatal mice.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. "The incidence of childhood cancer is increasing. One of the most common cancers for...

Critical reporting elements for quality of study methods reported.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Scientists have outlined critical reporting elements for quality of study methods in individual- and group-level HIV intervention research in a recent issue of AIDS Education and Prevention. "To...

Murine model of immunity induced by pneumococcal vaccine developed.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Scientists have developed a murine model for the study of immune memory in response to pneumococcal conjugate vaccination. According to recent research from the United States, "We developed a...

Change in polio vaccine policy eliminates cases of vaccine-associated polio.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A change in the U.S. polio vaccination policy has led to the elimination of vaccine-associated paralytic poliomyelitis (VAPP), according to a new study. The last case of poliomyelitis (polio) in...

Clinicopathologic study of West Nile Virus encephalomyelitis reported.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers have performed a clinicopathologic study and laboratory diagnosis of 23 cases with West Nile Virus encephalomyelitis. "The differences in pathologic findings of fatal cases of West Nile...

HIV-1 superinfections assessed by autologous heteroduplex mobility.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Scientists have assessed HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso by an autologous heteroduplex mobility procedure. In a recently published article, scientists in...

Current state of HIV and AIDS in Sub-Saharan Africa reviewed.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers review the current state of AIDS and HIV in Sub-Saharan Africa in a recent issue of the Croatian Medical Journal. According to a study from Malawi and the United States, "Sub-Saharan...

FDA approves medical device to treat AAA.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms...

Multiresistant Acinetobacter baumannii outbreak occurred in surgical room.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Multi-resistant Acinetobacter baumannii outbreak occurred in a surgical room in Germany. "Outbreaks of Acinetobacter baumannii demonstrating multiple antibiotic resistance, including meropenem...

U.S. HHS awards grants to treat co-occurring substance abuse/mental disorders.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- U.S. Health and Human Services (HHS) Secretary Tommy G. Thompson announced the award of 4 grants totaling $19.3 million over 5 years to increase the capacity of state treatment systems to provide...

Study documents adverse events of pneumococcal vaccine in children.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Examination of reports from the first 2 years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance...

Patient knowledge of allergy immunotherapy better than expected.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Patient knowledge of allergy immunotherapy was better than expected. "Immunotherapy is an invaluable therapy for allergic asthma, allergic rhinitis, and hymenoptera hypersensitivity. It is, however,...

Study of primary care doctors' response to 2001 attacks shows prudent care.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Primary care physicians working only blocks away from the New York City anthrax attacks of October 2001 acted responsibly and rationally in the midst of the crisis, according to New York-Presbyterian...

Synthetic zeolites used for arsenate removal from pollutant water.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Synthetic zeolites are used for arsenate removal from pollutant water. "Arsenic is known to be a hazardous contaminant in drinking water that causes arsenical dermatitis and skin cancer. In the...

Pharmaceutical company offers its alternative to recalled arthritis medication.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- With the recent recall of the arthritis medication rofecoxib, Boehringer Ingelheim announced that it is supporting patients while they look for new alternatives. The company offered up its own...

Reassortant influenza vaccines control avian influenza.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Scientists have generated reassortant influenza vaccines by reverse genetics that allows utilization of a Differentiating Infected from Vaccinated Animals (DIVA) strategy for the control of avian...

Biotech firm lauds Nobel winner, announces olfactory-based government contract.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Joseph K. Pagano, chairman of the board of Sentigen Holding Corp. (SGHL), a biotechnology company, extended congratulations to Dr. Richard Axel, Sentigen's long term good friend and consultant, on being...

Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Oligonucleotide array technology rapidly detects foodborne pathogenic bacteria. According to a study from China, "A rapid and accurate method for detection for common pathogenic bacteria in...

District of Columbia EHMSA licenses VisualDx diagnostic software.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Logical Images, a developer of point-of-care medical-diagnostic software, announced that VisualDx will support clinicians at 10 District of Columbia hospital emergency departments and 20 District of...

NIH grants awards for the development of human antibody against anthrax.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Medarex (MEDX) announced that it has received two grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to support Medarex's research and development of MDX-1303, a fully...

FDA approves ABILIFY for acute bipolar mania, including manic and mixed episodes.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Co. (BMY) and Otsuka Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved ABILIFY (aripiprazole) for the treatment of acute bipolar...

Agreement signed for distribution of bacterial detection system in Japan.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Pall Corporation (NYSE:PLL) announced that it has finalized an agreement for Kawasumi Laboratories, Inc., to become the exclusive provider of the Pall eBDS (enhanced Bacterial Detection System) in...

University study affirms efficacy of pheromone-based products, company says.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Human Pheromone Sciences, Inc. (EROX) confirmed that an independent study conducted by researchers at the University of California, Berkeley, and published in the journal, Psychoneuroendocrinology,...

Companies announce filing of MAA in Europe to inject anticancer drug for MDS.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc. (SUPG) and MGI Pharma Inc. (MOGN), announced that a marketing authorization application (MAA) seeking approval of Dacogen (decitabine) for injection has been submitted to the European...

DOD awards sole-source contract for the ThinPrep Pap Test.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Cytyc Corp. (CYTC) announced that it has won a sole-source contract from the United States Department of Defense (DOD) to provide the ThinPrep Pap Test as the platform for cervical cancer screening at...

Compounds with MDR1-enhanced anticancer activity identified.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Several novel anticancer compounds have demonstrated heightened activity in the presence of the MDR1 multidrug transporter. "For analysis of multidrug resistance, a major barrier to effective...

Protein biomarkers and drug design for cancer treatments reviewed.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers review protein biomarkers and drug design for cancer treatments in a recent issue of the European Journal of Cancer Prevention. "The development of new cancer treatments is quickly...

FDA approves marketing a newly developed cardiac monitor.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Criticare Systems, Inc., (CMD) (CSI) has received notification from the FDA (U.S. Food and Drug Administration) that it has been granted approval to market a cardiac monitor with magnetic resonance...

After initial damage, protective mechanisms within the heart were initiated.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers have reported the results of a short-term time-course study of bis(2-chloroethoxy) methane-induced mitochondrial and myofibrillar damage. Scientists writing in the journal Toxicological...

Infection site and patient ethnicity affect HPV-induced cancer pathways.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer. According to published research from Australia, "High-risk human papillomaviruses...

Socioeconomic disparities affect disease incidence and mortality in U.S.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Researchers with the U.S. National Cancer Institute (NCI) have identified time-related area socioeconomic disparities that affect cervical cancer incidence and mortality in the U.S. "Temporal...

Prevalence of overweight and obesity among Kuwaiti adolescents reported.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- An investigator summarizes body mass index and the prevalence of overweight and obesity among Kuwaiti intermediate school adolescents aged 10-14 years in a recent issue of the European Journal of...

Clinical investigators review, endorse phase 2 trials for deep vein therapy.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Agenix Limited [AGXLY] announced that clinical investigators to be involved in its phase 2 ThromboView deep vein thrombosis (DVT) clinical trial have met, reviewed and endorsed all aspects of the trial....

Company expands consulting services to full service clinical trials.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Developers of safe and effective pharmaceuticals, biologics, medical devices, and biotechnology products are in a highly competitive environment. Integrated, cost-conscious planning and execution of...

Drug improves Huntington disease movement disorder in clinical trial.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Phase 3 clinical data presented during the 18th Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders demonstrated that the investigational therapy...

Bionics cochlear auditory implants recalled worldwide.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that its subsidiary, Advanced Bionics Corporation of Sylmar, California, is voluntarily recalling worldwide all unimplanted Clarion and HiResolution...

Decision-making brains weigh up evidence.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Imagine trying to recognize someone in a teeming rainstorm. How do you decipher their blurry image and work out whether it is your friend? A brain-imaging study suggests that even tricky mental tasks...

E-mail surveys assist investigation and response in conjunctivitis outbreak.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- E-mail surveys can assist the investigation and response in a conjunctivitis outbreak. "A conjunctivitis outbreak affecting more than 200 individuals occurred on a university campus in Evanston,...

Company announces final research report on cystic fibrosis treatment.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Biotech company Medical Discoveries (MLSC) announced receipt of the last in a series of research reports required by the U.S. Food & Drug Administration (FDA) for the company's submission of an...

Foundation urges newborn screening for CF in test panels.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The Cystic Fibrosis Foundation has issued a recommendation for the implementation of routine cystic fibrosis (CF) screening in all newborns. The U.S. Centers for Disease Control and Prevention (CDC)...

HIV infection increases risk of dental caries in children.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- HIV infection increases the risk of dental caries in children. "The interrelationship of HIV infection, dental caries, and mucosal immune responses remains controversial. In our study population of...

FDA issues 510(k) clearance for Varilite dual wavelength laser.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- IRIDEX Corporation (IRIX) has received 510(k) clearance from the U.S. Food and Drug Administration for its new VariLite dual wavelength laser. The VariLite was cleared for 19 specific dermatology...

Researchers study sixth-graders to prevent type 2 diabetes.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- This fall Oregon Health & Science University is partnering with Aloha Park K-8 School in Beaverton, Oregon, in a pilot study to test whether changes in physical education (PE) classes, food choices in...

FDA approval granted for Metformin Hydrochloride 500 mg.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced that Purepac Pharmaceutical Co., a subsidiary of Alpharma, has received final approval from the U.S. Food and Drug Administration (FDA) for metformin hydrochloride...

U.S. NIH grant to fund human asthma testing with Breathmeter.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Ekips Technologies, Inc., has received a $750,000 phase II National Institutes of Health grant from the National Heart Lung and Blood Institute to support clinical studies for obtaining U.S. Food and...

U.S. FDA approves new and easy way to take ENBREL.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that the new 50 mg/mL prefilled syringe of Enbrel (etanercept) has been approved by the U.S. Food and Drug...

Pharmaceutical receives U.S. FDA approval of GI disease and hepatitis drugs.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the company's Abbreviated New Drug Application (ANDA) for Mesalamine Rectal...

Study results of treatment for leukemia with arsenic trioxide presented.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- An Iranian investigational study of single-agent arsenic trioxide for the treatment of acute promyelocytic leukemia (APL) was presented at the 16th Annual meeting of the European Organization for...

U.S. FDA grants orphan status to drug for treatment of soft tissue sarcoma.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to Yondelis in the indication of soft tissue sarcoma (STS). The sponsor of this application in the U.S. is...

Emerging pathogen suggests amphibian trade should be closely monitored.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- An emerging pathogen in an introduced amphibian species suggests that the amphibian trade should be closely monitored. "Chytridiomycosis is an emerging fungal disease of amphibians responsible for...

Diesel exhaust enhances expression of IL-13 in bronchial epithelium.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Diesel exhaust exposure enhances the expression of IL-13 in the bronchial epithelium of healthy subjects. According to recent research from Sweden and England, "Epidemiological studies have...

Company announces clinical hold on TNFerade trials.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- GenVec (GNVC) announced that the U.S. Food and Drug Administration (FDA) has requested that clinical trials of TNFerade be placed on hold, pending review of information pertaining to a potential...

Company raises $12 million to fund gene therapy.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- GENETIX Pharmaceuticals, Inc., has completed a $12 million private equity investment round to fund a phase I/II clinical trial of its pioneering LentiGlobin hemoglobin gene therapy for patients with...

NIH funds first national SNP genotyping center.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The National Center for Research Resources (NCRR), a component of the U.S. National Institutes of Health (NIH), announced that it will fund the first national center for high-throughput genotyping...

Food-borne illness strikes at least 2 billion people a year.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- At least 2 billion people a year get sick from contaminated food, and the number is growing, according to United Nations (U.N.) health agencies. Illness from food-borne disease, which can lead to...

Biogenic amines and bacteria analyzed in recalled canned anchovies.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Scientists have evaluated histamine and other biogenic amines and bacterial contamination in canned anchovies recalled by the U.S. Food and Drug Administration. According to recent research from...

Pharma company recieves FDA approval for nicotine gum and ibuprofen suspension.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The Perrigo Company (NASDAQ:PRGO) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polacrilex gum and prescription...

Comparative study of Legionnaire's disease published.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A team at the Institut Pasteur associated with the French National Center for Scientific Research (CNRS), and in collaboration with the National Reference Center for Legionella in Lyon, has compared the...

FDA gives final approval for Brimonidine Tartrate Ophthalmic Solution, 0.2% ANDA.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- IVAX Corporation (IVX) has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for brimonidine tartrate ophthalmic solution, 0.2%....

Protein patterns can be used to identify GBM subtypes.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Protein expression patterns can be used to identify subtypes of glioblastoma multiforme (GBM). According to recent research from the United States, GBM "has been subdivided into two types based on...

Debate-guidelines for glycopeptide-resistant enterococci control have not worked.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The debate-guidelines for glycopeptide-resistant enterococci control have not worked. "Glycopeptide-resistant enterococci (GRE) have become a focus of concern in many countries because options for...

HIV-1 non-B subtypes from heterosexual transmission predominate in Scotland.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- HIV-1 non-B subtypes acquired from heterosexual transmissions predominate in Scotland. According to a study from Scotland, "Historically, subtype B viruses in men who have sex with men (MSM) and...

Primary hotline questions in Netherlands regard HIV transmission/risk/testing.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Primary AIDS hotline questions in the Netherlands regard HIV transmission, HIV risk and HIV testing. According to recent research from the Netherlands, "AIDS telephone hotlines have an important...

APOBEC3G incorporated into HIV-1 virions through viral/nonviral RNA interactions.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- APOBEC3G is incorporated into HIV-1 virions through viral and nonviral RNA interactions. "Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is a host cytidine deaminase...

Host cell gene expression varies during HIV-1 latency or reactivation.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The host cell gene expression varies during HIV-1 latency or reactivation. "The existence of reservoirs of cells latently infected with human immunodeficiency virus (HIV) is a major obstacle to the...

Study: Fuzeon plus active boosted PI doubles long-term response.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Twice as many treatment-experienced patients who used Fuzeon (enfuvirtide) with an active boosted protease inhibitor (PI) regimen experienced a significant virologic response when compared to patients...

New PAHO fact sheets on HIV reflect differences in cost, care, coverage.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The Pan American Health Organization (PAHO) issued reports on the first 7 of 47 countries and territories with new and specific data on the care and treatment of people with HIV in the Americas. They...

Canadian biotech company begins two studies on cholesterol combination therapy.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Magistral Biotech (MBS) announced two new multi-center clinical studies that will study the effectiveness of Magistral's over-the-counter, cholesterol-lowering drug Libracol when taken concomitantly...

Clinical trials slated for choelsterol drug.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Danish company LifeCycle Pharma has announced the initiation of clinical trials on a new tablet formulation of fenofibrate, a cholesterol-lowering drug. "We expect to file for market authorization...

FDA grants priority review to Pegasys with Copegus for HCV in HIV patients.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has granted 6-month priority review status to the supplemental new biologics license application (sBLA) for Roche's combination therapy of Pegasys...

Gene expression patterns with prognostic value identified.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Gene expression profiles with prognostic value in hepatocellular carcinoma (HCC) have been identified. In a recent study, hepatologists in the United States, "analyzed global gene expression...

Drug receives orphan designation.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Medarex (MEDX) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Medarex's fully human anti-CD30 antibody, MDX-060, for the treatment of Hodgkin's...

FDA extends review period for contrast agent MS-325 by 3 months.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Schering, AG, (SHR) announced that its development partner, EPIX Pharmaceuticals, Inc., (EPIX) received notification that the U.S. Food and Drug Administration (FDA) has extended the new drug...

Lung image database consortium established for medical imaging researchers.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Lung image database consortium has been established for medical imaging research community. "To stimulate the advancement of computer-aided diagnostic (CAD) research for lung nodules in thoracic...

IL-7 has dose-dependent effects on T-cell development.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Interleukin-7 (IL-7) has dose-dependent effects on T-cell development. To determine the role of IL-7 in early thymocyte development, hematologists in the United States "generated mice transgenic...

Disinfection, and sterilization adherence reduce hospital-related infections.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Disinfection and sterilization adherence reduce contaminated hospital instrument-related infections. According to an article in the journal Clinical Infectious Diseases, "All invasive procedures...

Company awarded SIBR grant for infectious disease detection.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Meridian Bioscience (VIVO) announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) Grant from the U.S. National Institutes of Health (NIH). This Phase I Grant will...

Drug-DNA combination could offer longer-lasting, more efficient flu vaccine.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Research from Sweden suggests that adding the drug tucaresol to plasmid DNA influenza vaccines could offer longer-lasting and more efficient protection against the influenza virus. Annual flu...

Experts: Good hygiene can ward off flu.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The wisdom mothers have been dispensing for ages - wash your hands, eat your vegetables, go to bed earlier - turns out to be great advice for avoiding the flu. Doctors and nutritionists say careful...

Study to test flu shot and nasal spray flu vaccine side by side.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- A University of Michigan (U-M) influenza expert is beginning a 3-year direct comparison of the effectiveness of flu shots vs. nasal spray flu vaccine. Flu shots have been around since World War II,...

Survey of hospitals quantifies flu vaccine price gouging.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The American Society of Health-System Pharmacists has conducted a survey of more than 2800 hospital pharmacy directors in the U.S. about how the flu vaccine shortage is affecting their ability to care...

Thirty million doses of influenza vaccine shipped to healthcare providers.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Aventis (AVE), part of the sanofi-aventis Group, announced that the company has shipped more than 30 million doses of its influenza vaccine, Fluzone, Influenza Virus Vaccine, for the upcoming season....

U.S. CDC urges high-risk groups to get vaccinated, healthy people to wait.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- The loss of vaccine from Chiron Corp. has created a challenging situation for the United States vaccine supply going into this year's influenza season. The U.S. Centers for Disease Control and...

U.S. funding granted for new influenza drug.
November 7, 2004... 2004 NOV 7 - (NewsRx.com & NewsRx.net) -- Biota Holdings Limited announced that the U.S. government, via the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. National Institutes of Health (NIH), had awarded...